Literature DB >> 28766554

Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon.

R Bücker1, S M Krug1, V Moos2, C Bojarski2, M R Schweiger3, M Kerick3, A Fromm1, S Janßen2, M Fromm1, N A Hering4, B Siegmund2, T Schneider2, C Barmeyer2, J D Schulzke1.   

Abstract

Campylobacter jejuni is the most prevalent cause of foodborne bacterial enteritis worldwide. Patients present with diarrhea and immune responses lead to complications like arthritis and irritable bowel syndrome. Although studies exist in animal and cell models, we aimed at a functional and structural characterization of intestinal dysfunction and the involved regulatory mechanisms in human colon. First, in patients' colonic biopsies, sodium malabsorption was identified as an important diarrheal mechanism resulting from hampered epithelial ion transport via impaired epithelial sodium channel (ENaC) β- and γ-subunit. In addition, barrier dysfunction from disrupted epithelial tight junction proteins (claudin-1, -3, -4, -5, and -8), epithelial apoptosis, and appearance of lesions was detected, which cause leak-flux diarrhea and can perpetuate immune responses. Importantly, these effects in human biopsies either represent direct action of Campylobacter jejuni (ENaC impairment) or are caused by proinflammatory signaling (barrier dysfunction). This was revealed by regulator analysis from RNA-sequencing (cytometric bead array-checked) and confirmed in cell models, which identified interferon-γ, TNFα, IL-13, and IL-1β. Finally, bioinformatics' predictions yielded additional information on protective influences like vitamin D, which was confirmed in cell models. Thus, these are candidates for intervention strategies against C. jejuni infection and post-infectious sequelae, which result from the permissive barrier defect along the leaky gut.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28766554     DOI: 10.1038/mi.2017.66

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  46 in total

1.  Increase in the tight junction protein claudin-1 in intestinal inflammation.

Authors:  Lisa S Poritz; Leonard R Harris; Ashley A Kelly; Walter A Koltun
Journal:  Dig Dis Sci       Date:  2011-07-12       Impact factor: 3.199

2.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

3.  TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling.

Authors:  Maren Amasheh; Anja Fromm; Susanne M Krug; Salah Amasheh; Susanne Andres; Martin Zeitz; Michael Fromm; Jörg-Dieter Schulzke
Journal:  J Cell Sci       Date:  2010-11-09       Impact factor: 5.285

4.  Experimental Campylobacter jejuni infection in Macaca nemestrina.

Authors:  R G Russell; M J Blaser; J I Sarmiento; J Fox
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

5.  ENaC Dysregulation Through Activation of MEK1/2 Contributes to Impaired Na+ Absorption in Lymphocytic Colitis.

Authors:  Christian Barmeyer; Irene Erko; Anja Fromm; Christian Bojarski; Christoph Loddenkemper; Petra Dames; Martin Kerick; Britta Siegmund; Michael Fromm; Michal R Schweiger; Jörg-Dieter Schulzke
Journal:  Inflamm Bowel Dis       Date:  2016-03       Impact factor: 5.325

6.  Mechanisms of diarrhea in collagenous colitis.

Authors:  Natalie Bürgel; Christian Bojarski; Joachim Mankertz; Martin Zeitz; Michael Fromm; Jörg-Dieter Schulzke
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

7.  Interleukin-13 affects the epithelial sodium channel in the intestine by coordinated modulation of STAT6 and p38 MAPK activity.

Authors:  Petra Dames; Theresa Bergann; Anja Fromm; Roland Bücker; Christian Barmeyer; Susanne M Krug; Michael Fromm; Jörg-Dieter Schulzke
Journal:  J Physiol       Date:  2015-10-28       Impact factor: 5.182

8.  Experimental Campylobacter jejuni infection of adult mice.

Authors:  M J Blaser; D J Duncan; G H Warren; W L Wang
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  Campylobacter colitis: histological immunohistochemical and ultrastructural findings.

Authors:  J P van Spreeuwel; G C Duursma; C J Meijer; R Bax; P C Rosekrans; J Lindeman
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

10.  Rapid paracellular transmigration of Campylobacter jejuni across polarized epithelial cells without affecting TER: role of proteolytic-active HtrA cleaving E-cadherin but not fibronectin.

Authors:  Manja Boehm; Benjamin Hoy; Manfred Rohde; Nicole Tegtmeyer; Kristoffer T Bæk; Omar A Oyarzabal; Lone Brøndsted; Silja Wessler; Steffen Backert
Journal:  Gut Pathog       Date:  2012-04-25       Impact factor: 4.181

View more
  10 in total

Review 1.  Abundant Monovalent Ions as Environmental Signposts for Pathogens during Host Colonization.

Authors:  Shumin Tan
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

2.  Drivers of transcriptional variance in human intestinal epithelial organoids.

Authors:  Zachary K Criss; Nobel Bhasin; Sara C Di Rienzi; Anubama Rajan; Kali Deans-Fielder; Ganesh Swaminathan; Nabiollah Kamyabi; Xi-Lei Zeng; Harsha Doddapaneni; Vipin K Menon; Deepavali Chakravarti; Clarissa Estrella; Xiaomin Yu; Ketki Patil; Joseph F Petrosino; James C Fleet; Michael P Verzi; Sylvia Christakos; Michael A Helmrath; Sumimasa Arimura; Ronald A DePinho; Robert A Britton; Anthony W Maresso; K Jane Grande-Allen; Sarah E Blutt; Sue E Crawford; Mary K Estes; Sasirekha Ramani; Noah F Shroyer
Journal:  Physiol Genomics       Date:  2021-10-06       Impact factor: 3.107

3.  Diarrheal Mechanisms and the Role of Intestinal Barrier Dysfunction in Campylobacter Infections.

Authors:  Fábia Daniela Lobo de Sá; Jörg-Dieter Schulzke; Roland Bücker
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

4.  Reaction of antibodies to Campylobacter jejuni and cytolethal distending toxin B with tissues and food antigens.

Authors:  Aristo Vojdani; Elroy Vojdani
Journal:  World J Gastroenterol       Date:  2019-03-07       Impact factor: 5.742

5.  Campylobacter concisus Impairs Sodium Absorption in Colonic Epithelium via ENaC Dysfunction and Claudin-8 Disruption.

Authors:  Praveen Kumar Nattramilarasu; Roland Bücker; Fábia Daniela Lobo de Sá; Anja Fromm; Oliver Nagel; In-Fah Maria Lee; Eduard Butkevych; Soraya Mousavi; Claudia Genger; Sigri Kløve; Markus M Heimesaat; Stefan Bereswill; Michal R Schweiger; Hans Linde Nielsen; Hanno Troeger; Jörg-Dieter Schulzke
Journal:  Int J Mol Sci       Date:  2020-01-07       Impact factor: 5.923

6.  Immune-Mediated Aggravation of the Campylobacter concisus-Induced Epithelial Barrier Dysfunction.

Authors:  Praveen Kumar Nattramilarasu; Fábia Daniela Lobo de Sá; Jörg-Dieter Schulzke; Roland Bücker
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

7.  Painong San, a Traditional Chinese Compound Herbal Medicine, Restores Colon Barrier Function on DSS-Induced Colitis in Mice.

Authors:  Xuelin Rui; Jiacheng Li; Ye Yang; Li Xu; Yang Liu; Mengmeng Zhang; Dengke Yin
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-20       Impact factor: 2.629

Review 8.  Resveratrol in Intestinal Health and Disease: Focusing on Intestinal Barrier.

Authors:  Youxia Wang; Changming Hong; Zebiao Wu; Shuwei Li; Yaoyao Xia; Yuying Liang; Xiaohua He; Xinyu Xiao; Wenjie Tang
Journal:  Front Nutr       Date:  2022-03-16

9.  Contribution of Epithelial Apoptosis and Subepithelial Immune Responses in Campylobacter jejuni-Induced Barrier Disruption.

Authors:  Eduard Butkevych; Fábia Daniela Lobo de Sá; Praveen Kumar Nattramilarasu; Roland Bücker
Journal:  Front Microbiol       Date:  2020-03-06       Impact factor: 5.640

Review 10.  Micronutrient Improvement of Epithelial Barrier Function in Various Disease States: A Case for Adjuvant Therapy.

Authors:  Katherine M DiGuilio; Elizabeth Rybakovsky; Reza Abdavies; Romy Chamoun; Colleen A Flounders; Ariel Shepley-McTaggart; Ronald N Harty; James M Mullin
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.